Skip to main content
. 2016 Jul 16;12:142. doi: 10.1186/s12917-016-0772-y

Fig. 1.

Fig. 1

Immunohistochemical staining for KIT. a Strong immunolabelling in the cytoplasm of Purkinje cells of a NCC was used as a positive control for KIT immunostaining. b Expression of KIT was not detected in a HA. c Strong immunoreactivities were observed inasplenic HSA with stage III and grade 3. d Positive immunoreactivities were observed ina cutaneous HSA with stage III and grade 2. Sections counterstained with hematoxylin. Bar = 50 μm